X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs IPCA LABS - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK IPCA LABS MERCK/
IPCA LABS
 
P/E (TTM) x 50.9 25.9 196.0% View Chart
P/BV x 8.9 4.4 202.4% View Chart
Dividend Yield % 0.4 0.1 357.4%  

Financials

 MERCK   IPCA LABS
EQUITY SHARE DATA
    MERCK
Dec-17
IPCA LABS
Mar-18
MERCK/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,358695 195.2%   
Low Rs933400 233.3%   
Sales per share (Unadj.) Rs665.0260.2 255.6%  
Earnings per share (Unadj.) Rs56.619.0 298.2%  
Cash flow per share (Unadj.) Rs72.533.1 219.3%  
Dividends per share (Unadj.) Rs15.001.00 1,500.0%  
Dividend yield (eoy) %1.30.2 717.4%  
Book value per share (Unadj.) Rs441.7213.0 207.3%  
Shares outstanding (eoy) m16.60126.20 13.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.72.1 81.8%   
Avg P/E ratio x20.228.9 70.1%  
P/CF ratio (eoy) x15.816.6 95.4%  
Price / Book Value ratio x2.62.6 100.8%  
Dividend payout %26.55.3 503.0%   
Avg Mkt Cap Rs m19,01169,120 27.5%   
No. of employees `0001.513.3 11.6%   
Total wages/salary Rs m1,6967,359 23.1%   
Avg. sales/employee Rs Th7,150.02,477.4 288.6%   
Avg. wages/employee Rs Th1,098.7555.2 197.9%   
Avg. net profit/employee Rs Th608.2180.6 336.7%   
INCOME DATA
Net Sales Rs m11,04032,836 33.6%  
Other income Rs m240418 57.3%   
Total revenues Rs m11,27933,254 33.9%   
Gross profit Rs m1,3764,505 30.5%  
Depreciation Rs m2641,777 14.9%   
Interest Rs m0240 0.0%   
Profit before tax Rs m1,3522,905 46.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m583511 114.0%   
Profit after tax Rs m9392,394 39.2%  
Gross profit margin %12.513.7 90.9%  
Effective tax rate %43.117.6 245.1%   
Net profit margin %8.57.3 116.7%  
BALANCE SHEET DATA
Current assets Rs m7,52319,455 38.7%   
Current liabilities Rs m2,25310,076 22.4%   
Net working cap to sales %47.728.6 167.1%  
Current ratio x3.31.9 173.0%  
Inventory Days Days5298 53.3%  
Debtors Days Days4167 60.6%  
Net fixed assets Rs m1,24020,260 6.1%   
Share capital Rs m166252 65.8%   
"Free" reserves Rs m7,16726,633 26.9%   
Net worth Rs m7,33326,886 27.3%   
Long term debt Rs m02,340 0.0%   
Total assets Rs m9,91241,173 24.1%  
Interest coverage xNM13.1-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.10.8 139.7%   
Return on assets %9.56.4 148.1%  
Return on equity %12.88.9 143.8%  
Return on capital %20.810.8 192.8%  
Exports to sales %047.6 0.0%   
Imports to sales %014.9 0.0%   
Exports (fob) Rs mNA15,642 0.0%   
Imports (cif) Rs mNA4,884 0.0%   
Fx inflow Rs m1,01515,642 6.5%   
Fx outflow Rs m3,0434,884 62.3%   
Net fx Rs m-2,02810,759 -18.9%   
CASH FLOW
From Operations Rs m5373,411 15.7%  
From Investments Rs m-476-1,354 35.2%  
From Financial Activity Rs m-220-1,304 16.9%  
Net Cashflow Rs m-160753 -21.2%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 11.4 159.6%  
FIIs % 1.0 25.3 4.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.4 167.2%  
Shareholders   28,591 36,892 77.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   ALEMBIC LTD  SUN PHARMA  SANOFI INDIA  FDC LTD.  AUROBINDO PHARMA  

Compare MERCK With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Jet Airways and Yes Bank - What's Next for these Beaten Down Stocks?(Podcast)

Jet Airways and Yes Bank, both once market darlings are now being shunned by market participants. The National Stock Exchange (NSE) exchange notified that the shares of the airline.

Related Views on News

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

The Best 4 Small-cap Stocks to Buy(The 5 Minute Wrapup)

Jun 3, 2019

In the sometimes good sometimes bad market of small caps, there are strong buying opportunities available today. But this great opportunity won't last forever.

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Top 7 Stocks to Profit from Modi's Repeat Performance(Profit Hunter)

Jun 3, 2019

The long-term India story looks promising with the Modi government back in power. Which stocks are likely to go up the most?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Jun 14, 2019 (Close)

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS